|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PUBLIC HEALTH THEN AND NOW |
The author is with The Trent Center for Bioethics, Humanities, and History of Medicine, Duke University School of Medicine, Durham, NC.
Correspondence: Correspondence should be sent to Jeffrey P. Baker, MD, PhD, Trent Center for Bioethics, Humanities, and History of Medicine, Duke University School of Medicine, Box 3040 Duke University Medical Center, Durham, NC 27710 (e-mail: Baker009{at}mc.duke.edu).
The controversy regarding the once widely used mercury-containing preservative thimerosal in childhood vaccines has raised many historical questions that have not been adequately explored. Why was this preservative incorporated in the first place? Was there any real evidence that it caused harm? And how did thimerosal become linked in the public mind to the "autism epidemic"?
I examine the origins of the thimerosal controversy and their legacy for the debate that has followed. More specifically, I explore the parallel histories of three factors that converged to create the crisis: vaccine preservatives, mercury poisoning, and autism.
An understanding of this history provides important lessons for physicians and policymakers seeking to preserve the publics trust in the nations vaccine system.
This article has been cited by other articles:
![]() |
E. K. Silbergeld MERCURY, VACCINES, AND AUTISM, REVISITED Am J Public Health, August 1, 2008; 98(8): 1350 - 1350. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |